Background: Care and management of patients with congestive heart failure (CHF) is a major health-care challenge. The value of acute hemodynamic data in assessing heart failure has been questioned in ...

The annual health care cost incurred by heart failure patients is about $56 billion, two thirds of which is spent on management of acutely decompensated patients. Hemodynamic evaluation is helpful for ...

A new publication from Opto-Electronic Advances, 10.29026/oea.2023.230018 discusses Spatiotemporal hemodynamic monitoring via configurable skin-like microfiber Bragg grating group. Cardiovascular ...

Hemodynamic Monitoring Devices Market size is projected to accrue USD 2.5 billion in revenue by 2032. The demand for hemodynamic monitoring devices is witnessing a rise due to new product launches for ...

Continuous, reliable and real-time assessment of major determinants of cardiovascular function in preterm and term neonates has long been an elusive aim in neonatal medicine. Accordingly, aside from ...

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Caretaker Medical, a pioneer in wireless “beat by beat” continuous, non-invasive, advanced patient monitoring, today announced U.S. Food and Drug Administration ...

BD (Becton, Dickinson and Company) has launched a new medical device designed to give clinicians continuous, noninvasive visibility into patients’ blood pressure. Dubbed the HemoSphere Stream Module, ...

Please provide your email address to receive an email when new articles are posted on . In a meta-analysis of three trials, remote hemodynamic monitoring was associated with reduced risk for death and ...

Please provide your email address to receive an email when new articles are posted on . A noninvasive monitoring system identified short-term hemodynamic changes early after transcatheter aortic valve ...

Fifth Eye, a Michigan-based real-time clinical analytics company, announced today that the Food and Drug Administration has granted De Novo classification for its Analytic for Hemodynamic Instability ...